I Khan, S Zaib, S Batool, N Abbas, Z Ashraf… - Bioorganic & medicinal …, 2016 - Elsevier
Nitrogen-rich heterocycles, particularly quinazolines and quinazolinones, represent a unique class of diversified frameworks displaying a broad spectrum of biological functions …
A novel series of quinazolinone-1, 2, 3-triazole hybrids 10a-p were designed, synthesized, and evaluated for their in vitro α-glucosidase inhibitory activity leading to efficient anti …
Z Liu, S Ma - ChemMedChem, 2017 - Wiley Online Library
Over the past few years, the number of people diagnosed with type 2 diabetes has increased owing to an unhealthy diet, a limited amount of exercise, and obesity. The search …
Cancer is one of the leading causes of death. Globally a huge number of deaths and new incidences are reported annually. Heterocyclic compounds have been proved to be very …
In this study, a new series of quinazolinone-pyrazole hybrids were designed, synthesized and screened for their α-glucosidase inhibitory activity. The results of the in vitro screening …
MM Khalifa, HM Sakr, A Ibrahim, AM Mansour… - Journal of Molecular …, 2022 - Elsevier
A novel series of benzylidene-quinazolinone hybrids 8 a, b and 10 an were designed, synthesized, and evaluated for their in vitro α-glucosidase inhibitory effect aiming to discover …
F Peytam, F Hosseini, M Hekmati, B Bayati… - Scientific Reports, 2023 - nature.com
Abstract α-Glucosidase inhibition is an approved treatment for type 2 diabetes mellitus (T2DM). In an attempt to develop novel anti-α-glucosidase agents, two series of substituted …
A Barmak, K Niknam, G Mohebbi - ACS omega, 2019 - ACS Publications
A series of new quinazoline derivatives were designed and synthesized via a one-pot condensation reaction between isatoic anhydride and aromatic aldehydes with anilines …
Previously, we synthesized triazoloquinazolines 1–14 and characterized their structure. In this study, we aimed to evaluate the in vitro activity of the targets 1–14 as α-glucosidase …